Skip to content

Clinical trials

Completed Hepatitis C trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Status: Completed Country / region: Australia Clear all

83 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20051
20062
20073
20081
20093
20106
201114
201212
20138
20148
20157
20165
20174
20194
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed83

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences17
Bristol-Myers Squibb15
Kirby Institute14
AbbVie5
Debiopharm International SA4
GlaxoSmithKline4
Janssen R&D Ireland4
Macfarlane Burnet Institute for Medical Research and Public Health Ltd4
Human Genome Sciences Inc.3
Tibotec Pharmaceuticals, Ireland2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C83
Hepatitis C, Chronic23
Bronchiolitis Obliterans Syndrome6
Hepatitis6
Fibrosis3
Acquired Immunodeficiency Syndrome1
Chronic Pain1
Communicable Diseases1
Disease1
Drug Misuse1

Trials

Showing 1 to 25 of 83. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.